Abstract
The inhibition of scorpion extracts on esophageal cancer and lung adenocarcinoma cells has been reported by previous studies, but the specific anti-tumor efficacy and potential molecular mechanism have not been clarified. In this study, we first modified the optimal enzymolysis and inactivation technology by imitating gastric and intestinal enzyme, and then investigated the antitumor effect of scorpion extracts both in vitro and in vivo. Our results showed that scorpion alcohol extraction with or without enzymolysis and fermentation could inhibit the cell proliferation of esophageal cancer and lung adenocarcinoma, and tumor growth in S180 tumor burden mice. In addition, the SOD activity increased by scorpion extracts, but MDA content decreased. The scorpion alcohol extracts without fermentation and enzymolysis exert inhibitory effect on the growth of esophageal cancer cells, and unenzymolytic fermented extracts have strong inhibitory effect on the growth of lung cancer cells. The scorpion and its extracts may serve as a new therapeutic agent to suppress tumor growth probably by promoting the function of immune organs and enhancing the activity of the immune system.
Keywords: Esophageal cancer, lung cancer, scorpion, therapy.
Graphical Abstract
Current Signal Transduction Therapy
Title:Scorpion Extracts Inhibit Tumor Growth in Esophageal Cancer and Lung Adenocarcinoma
Volume: 11 Issue: 1
Author(s): Yixuan Dong, Jihui Wang, Jing Li and Wei Li
Affiliation:
Keywords: Esophageal cancer, lung cancer, scorpion, therapy.
Abstract: The inhibition of scorpion extracts on esophageal cancer and lung adenocarcinoma cells has been reported by previous studies, but the specific anti-tumor efficacy and potential molecular mechanism have not been clarified. In this study, we first modified the optimal enzymolysis and inactivation technology by imitating gastric and intestinal enzyme, and then investigated the antitumor effect of scorpion extracts both in vitro and in vivo. Our results showed that scorpion alcohol extraction with or without enzymolysis and fermentation could inhibit the cell proliferation of esophageal cancer and lung adenocarcinoma, and tumor growth in S180 tumor burden mice. In addition, the SOD activity increased by scorpion extracts, but MDA content decreased. The scorpion alcohol extracts without fermentation and enzymolysis exert inhibitory effect on the growth of esophageal cancer cells, and unenzymolytic fermented extracts have strong inhibitory effect on the growth of lung cancer cells. The scorpion and its extracts may serve as a new therapeutic agent to suppress tumor growth probably by promoting the function of immune organs and enhancing the activity of the immune system.
Export Options
About this article
Cite this article as:
Dong Yixuan, Wang Jihui, Li Jing and Li Wei, Scorpion Extracts Inhibit Tumor Growth in Esophageal Cancer and Lung Adenocarcinoma, Current Signal Transduction Therapy 2016; 11 (1) . https://dx.doi.org/10.2174/1574362411666160210232741
DOI https://dx.doi.org/10.2174/1574362411666160210232741 |
Print ISSN 1574-3624 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-389X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Postoperative Thoracic Epidural Anesthesia in Gastrointestinal Surgery: Outcomes, Quality of Life, and Current Controversies
Current Drug Therapy Review on Documented Medicinal Plants used for the Treatment of Cancer
Current Traditional Medicine In Situ Gels Based Drug Delivery Systems
Current Drug Therapy Genetic and Epigenetic Studies for Determining Molecular Targets of Natural Product Anticancer Agents
Current Cancer Drug Targets Pathobiology and Therapeutic Implications of Tumor Acidosis
Current Medicinal Chemistry PET in Anti-Cancer Drug Development and Therapy
Recent Patents on Anti-Cancer Drug Discovery A Review of Depsipeptide and Other Histone Deacetylase Inhibitors in Clinical Trials
Current Pharmaceutical Design Extraction and Detection Techniques for PAHs Determination in Beverages: A Review
Current Chromatography Role of Lipoxins and Resolvins as Anti-Inflammatory and Proresolving Mediators in Colon Cancer
Current Molecular Medicine Imaging of Tumor Angiogenesis: Current Approaches and Future Prospects
Current Pharmaceutical Design Targeting CXCL12/CXCR4 Axis in Tumor Immunotherapy
Current Medicinal Chemistry Approaches Targeting KV10.1 Open a Novel Window for Cancer Diagnosis and Therapy
Current Medicinal Chemistry Arene ruthenium(II) Complexes: The Promising Chemotherapeutic Agent in Inhibiting the Proliferation, Migration and Invasion
Mini-Reviews in Medicinal Chemistry Head and Neck Cancer Treatments through Chemotherapy to Magnetic Systems: Perspectives and Challenges
Current Radiopharmaceuticals Revealing Insights into Natural Products Against mcr-1-Producing Bacteria
Current Drug Targets Candida parapsilosis Secreted Lipase as an Important Virulence Factor
Current Protein & Peptide Science Reviewing the Cardiovascular Complications of HIV Infection After the Introduction of Highly Active Antiretroviral Therapy
Current Drug Targets - Cardiovascular & Hematological Disorders Photothermal Therapy: A New Approach to Eradicate Cancer
Current Nanoscience Editorial (Thematic Issue: Harmful and Beneficial Effect of Aspirin on Gastrointestinal Tract)
Current Pharmaceutical Design Biological Modulation by Lectins and Their Ligands in Tumor Progression and Metastasis
Anti-Cancer Agents in Medicinal Chemistry